SSRI Monitoring recommendation Frequency Suggestion
{"Image DocumentName": "SSRI Monitoring recommendation Frequency Suggestion", "Image ImageDescription": "Measure Height and weight. Inquire about bleeding/bruising. Inquire about activation symptoms. Inquire about new suicidal thoughts. Determine if treatment response. At baseline and each follow-up, at least every 6 months. At least once after initiation of medication. Screen for new irritability or agitation around week 2 & week 4-6. Screen for suicidality around week 2, week 4-6, and other visits such as after dose increases. Repeat disorder specific rating scale(s) until remission is achieved. Increase at 4-6 week intervals if insufficient benefit. PAL Conference. March 24, 2011.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}